L’Oréal adds to Saturated Market of A.I Skin Diagnostic tools via Cosmetics Business

The AI tool, powered by L’Oréal-owned Modiface, uses 6,000 clinical images from its database to deliver accurate visual signs of ageing

L’Oréal and its recently acquired augmented reality (AR) and artificial intelligence (AI) entity Modiface have teamed up to introduce a new digital skin diagnostic tool.

The new AI powered SkinConsult – for the company’s Vichy brand – has been trained using 6,000 images from its Skin Ageing Atlases database in order to deliver accurate skin assessment for all skin types.

Three groups of women from Asian, Caucasian and African ethnicities were used in the image collection process across Japan, France, China, India and the US.

The Vichy SkinConsult will provide customers with a tailored diagnostic in three steps.

Customers can upload a selfie to the brand’s website, after which they will receive feedback on fine lines, dark spots, wrinkles and pores before receiving a tailored product routine to address these concerns.

L’Oréal’s Chief Digital Officer, Lubomira Rochet, said: “With the acquisition of Modiface, we have started a second phase of L’Oréal’s digital transformation, focused on reinventing the beauty experience through technologies such as voice, AR and AI.

“We believe that services will be the new gateways for discovering our brands and products.”

Users will also be able to understand their skin ageing process through the tool, rather than just being offered treatments.

Read more…

Recent Posts

Save the Date: April 28th, Testing Trends Webinar – Feedback on the Testing and Lab Zone x in-cosmetics global

👉 Register: Exclusive webinar in English April 28th 2025 at 3:00 PM [CEST]   We…

Save the Date: May 8th – What’s trending in cosmetics, A.I and other things! Webinar via Personal Care Insights

HOW AI IS SHAPING BIO-BASED BEAUTY AND PERSONALIZED PRODUCTS 📆 May, 8th 2025 ⏱️ 16:00…

Advancing AI-assisted drug discovery with the translational power of EEG via PsychoGenics

eCube® is a pharmaco-EEG platform that collects data from novel compounds and subsequently compares their…